Apheresis Market Surges to USD 6.3 Billion by 2031, Propelled by 12.6% CAGR - Verified Market Research®

The apheresis market is driven by rising demand for blood components, advancements in apheresis technology, and increasing prevalence of chronic diseases. Growing awareness and supportive government policies further boost the market. However, high procedure costs and risks associated with apheresis, such as bleeding and infection, restrain market growth. Additionally, the scarcity of skilled professionals and stringent regulatory frameworks pose significant challenges to the market's expansion.


Lewes, Delaware, June 06, 2024 (GLOBE NEWSWIRE) -- The Global Apheresis Market is projected to grow at a CAGR of 12.6% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 3.99 Billion in 2024 and is expected to reach USD 6.3 Billion by the end of the forecast period.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=23921

Browse in-depth TOC onGlobal Apheresis Market

202 - Pages

126 – Tables

37 – Figures

Scope Of The Report

REPORT ATTRIBUTESDETAILS
STUDY PERIOD2021-2031
BASE YEAR2024
FORECAST PERIOD2024-2031
HISTORICAL PERIOD2021-2023
UNITValue (USD Billion)
KEY COMPANIES PROFILEDFresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation, B. Braun Melsungen AG, Asahi Kasei Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., HemaCare Corporation, Kaneka Corporation, Grifols, S.A.
SEGMENTS COVEREDBy End User, By Technology, By Application, By Geography
CUSTOMIZATION SCOPEFree report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Apheresis Market Overview

Rising Demand for Blood Components: The growing demand for blood components is a significant factor contributing to the expansion of the apheresis market. Hospitals and clinics significantly depend on plasma, platelets, and red blood cells for a wide range of therapies, including trauma care and chronic illness management. The demand for apheresis operations is steady, which drives market growth and promotes technological improvements and investments in the field.

Technological Advancements in Apheresis: The market is being driven greatly by innovations in apheresis technology. Apheresis machines of today provide increased patient comfort, safety, and efficiency. These developments not only improve procedure results but also broaden the range of possible uses for apheresis. As a result, more healthcare providers will choose to use these innovative treatments, which will propel market growth.

Increasing Prevalence of Chronic Diseases: The market for apheresis is boosted by the increased prevalence of chronic illnesses like cancer, autoimmune diseases, and cardiovascular diseases. Apheresis is essential for the management of many illnesses because it makes tailored therapy and symptom alleviation possible. This pattern emphasizes how important apheresis is, which raises adoption rates and stimulates market expansion.

High Procedure Costs: The high expense of apheresis operations is still a major barrier, despite its advantages. Many healthcare facilities may find the cost of apheresis equipment, maintenance, and operating needs to be unaffordable, especially in lower-income areas. Notwithstanding the clear clinical benefits, this financial barrier prevents market expansion and restricts general adoption.

Risks Associated with Apheresis: The market is significantly constrained by the possible dangers associated with apheresis operations, which include bleeding, infections, and bad reactions. These dangers may discourage medical professionals and patients from choosing apheresis, which would slow the market's rate of expansion. Expanding the business requires addressing these safety concerns through strict regulations and innovation.

Scarcity of Skilled Professionals: The lack of skilled workers presents a problem for the apheresis industry. Procedures involving apheresis demand specific knowledge and experience, which are not always accessible. Because of this scarcity, healthcare providers are less able to deliver apheresis services, which lowers the market's potential for growth and accessibility.

Geographic Dominance:

Because of its sophisticated healthcare system, high rate of adoption of cutting-edge medical technology, and strong presence of major companies in the industry, North America leads the apheresis market. The region's leadership position is further reinforced by the significant investments it makes in research and development as well as the regulations that encourage it. Furthermore, rising awareness of the advantages of apheresis and the prevalence of chronic illnesses are driving market demand and guaranteeing North America's sustained leadership in the worldwide apheresis market.

Apheresis Market Key Players Shaping the Future

Major players, including Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation, B. Braun Melsungen AG, Asahi Kasei Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., HemaCare Corporation, Kaneka Corporation, Grifols, S.A. and more, play a pivotal role in shaping the future of the Apheresis Market. Financial statements, product benchmarking, and SWOT analysis provide valuable insights into the industry's key players.

Apheresis Market Segment Analysis

Based on the research, Verified Market Research® has segmented the global Apheresis Market into End User, Technology, Application, And Geography.

To get market data, market insights, and a comprehensive analysis of the Global Apheresis Market, please Contact Verified Market Research®.

  • Apheresis Market, by End User
    • Hospitals and Clinics
    • Blood banks and transfusion centers
    • Ambulatory Surgical Centers
  • Apheresis Market, by Technology
    • Centrifugation
    • Membrane filtering
  • Apheresis Market, by Application
    • Therapeutic apheresis
    • Donor Apheresis
  • Apheresis Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Global Pharmaceutical Excipients Market Size By Product (Organic Chemicals, Inorganic Chemicals), By Formulation (Oral Formulations, Parenteral Formulations), By Functionality (Fillers And Diluents, Binders), By Geography, And Forecast

Global Nuclear Medicine Market Size By Type (Diagnostic and Therapeutic), Application (Neurology, Cardiology), End-user (Hospitals & Clinics, Diagnostic Centers), By Geography, And Forecast

Global Molecular Biology Enzymes And Kits And Reagents Market Size By Product (Kits And Reagents, Enzymes, Polymerases, Ligases), By Application (Polymerase Chain Reaction (PCR), Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Centers), By Geography, And Forecast

Global Chromoendoscopy Agents Market Size By Product Type (Absorptive Agent, Reactive Agent, Contrast Agent), By Application (Gastric, Esophageal, Colorectal), By End-User (Hospital, Ambulatory Surgical Center, Diagnostic Center), By Geography, And Forecast

Top 10 Point-Of-Care Diagnostics Companies pushing latent capacity for patients’ recuperation

Visualize Apheresis Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® stands at the forefront as a global leader in Research and Consulting, offering unparalleled analytical research solutions that empower organizations with the insights needed for critical business decisions. Celebrating 10+ years of service, VMR has been instrumental in providing founders and companies with precise, up-to-date research data.

With a team of 500+ Analysts and subject matter experts, VMR leverages internationally recognized research methodologies for data collection and analyses, covering over 15,000 high impact and niche markets. This robust team ensures data integrity and offers insights that are both informative and actionable, tailored to the strategic needs of businesses across various industries.

VMR's domain expertise is recognized across 14 key industries, including Semiconductor & Electronics, Healthcare & Pharmaceuticals, Energy, Technology, Automobiles, Defense, Mining, Manufacturing, Retail, and Agriculture & Food. In-depth market analysis cover over 52 countries, with advanced data collection methods and sophisticated research techniques being utilized. This approach allows for actionable insights to be furnished by seasoned analysts, equipping clients with the essential knowledge necessary for critical revenue decisions across these varied and vital industries.

Verified Market Research® is also a member of ESOMAR, an organization renowned for setting the benchmark in ethical and professional standards in market research. This affiliation highlights VMR's dedication to conducting research with integrity and reliability, ensuring that the insights offered are not only valuable but also ethically sourced and respected worldwide.

 

Contact Data